For research and educational purposes only. Not medical advice.
Teriparatide Reference
Educational, not medical advice reference for Teriparatide: Bone, Hormonal; regulatory status, evidence posture, source review, and schedule notes. Also know…
Reference summary
Teriparatide is a label-verified prescription drug with decades of approved-label osteoporosis evidence. pepSmart surfaces label-reference content only and is not a prescribing tool.
- Categories
- Bone, Hormonal
- Aliases
- Forteo, rhPTH(1-34), Parathyroid hormone 1-34
- Evidence posture
- human
- Regulatory status
- FDA-approved prescription medication (Forteo). Labeled for osteoporosis treatment in postmenopausal women and men at high risk of fracture, and for glucocorticoid-induced osteoporosis. Cumulative lifetime exposure (teriparatide plus abaloparatide) should not exceed 2 years per label.
- Content review status
- label verified